MADRIGAL PHARMACEUTICALS INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 353,155 | $116,975,531 | 0.33% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 350,289 | $106,011,463 | 0.28% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 29, 2025 |
| Sept. 30, 2025 | 411,802 | $188,877,105 | 0.49% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 354,220 | $206,276,475 | 0.58% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 9, 2026 |
| March 31, 2026 | 340,519 | $178,251,481 | 0.59% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 8, 2026 |
| June 30, 2026 | 324,123 | $174,037,845 | 0.52% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.